National Institute of Diabetes
Overview
The National Institute of Diabetes is a leading public organization dedicated to research and education on diabetes and related diseases. It focuses on improving health outcomes through scientific research and public health initiatives.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to National Institute of Diabetes in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Amylin Pharmaceuticals, LLC
USA
EndocrineHealth Pharmaceuticals Inc.
USA
Global Diabetes Research Organization
United States
TheracosBio
United States
Advanced Diabetes Supply
United States
Aegerion Pharmaceuticals, Inc.
United States
Alexion Pharmaceuticals, Inc.
United States
BioMarin Pharmaceutical Inc.
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.